Director of CAPKR and Chief Scientific Officer
Certara / University of Manchester
Manchester, United Kingdom
The scientific work of Professor Rostami covers wide areas of drug development over last 30 years, ranging from pharmaceutics to clinical pharmacology and beyond.
As a leader in the field of Physiologically-based Pharmacokinetics and Quantitative Systems Pharmacology, Amin is internationally recognized for his expertise in the use of IVIVE to predict the behaviour of drugs in human body and understanding the associated inter-individual variabilities under the so called “bottom up” modelling.
Amin is a Professor of Systems Pharmacology and the Director of Centre for Applied Pharmacokinetic Research at the University of Manchester. In addition, he is the SVP and CSO at Certara. He facilitates the incorporation of the latest advances in translational modelling to biosimulation platforms offered by Certara to its pharmaceutical clients to accelerate regulatory approvals and bring safer drug products to the patients faster.
More than 300 highly cited articles have been authored by Amin (>19,500 citations, H-Factor = 76).
In 2017 the Institute of Scientific Information listed him as one of the world’s most highly cited researchers (under ‘Pharmacology & Toxicology’). He is 0.06% top rank of the Highly Cited Researchers List by Elsevier for pharmacology (2020). He serves on the Editorial Boards of several journals.
Disclosure information not submitted.
Tuesday, October 18, 2022
3:30 PM – 3:45 PM ET
Wednesday, October 19, 2022
9:30 AM – 10:00 AM ET
Wednesday, October 19, 2022
3:45 PM – 4:00 PM ET